Literature DB >> 5838362

The ocular toxic findings with prolonged and high dosage chlorpromazine intake.

J R Siddall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5838362     DOI： 10.1001/archopht.1965.00970040462005

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  12 in total

1.  Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry.

Authors:  Fernando Caravaggio; Enzo Scifo; Etienne L Sibille; Sergio E Hernandez-Da Mota; Philip Gerretsen; Gary Remington; Ariel Graff-Guerrero
Journal:  Exp Eye Res       Date:  2018-06-05       Impact factor: 3.467

2.  Ocular effects of chlorpromazine and oxypertine on beagle dogs.

Authors:  J Legros; I Rosner; C Berger
Journal:  Br J Ophthalmol       Date:  1971-06       Impact factor: 4.638

3.  Distribution and movement of ions in the ocular lens.

Authors:  C A Paterson
Journal:  Doc Ophthalmol       Date:  1972-04-15       Impact factor: 2.379

4.  Toxic effects of phenothiazines on the eye.

Authors:  D J Boet
Journal:  Doc Ophthalmol       Date:  1970-07-24       Impact factor: 2.379

5.  The toxicity of diquat.

Authors:  D G Clark; E W Hurst
Journal:  Br J Ind Med       Date:  1970-01

Review 6.  Adverse ocular reactions to drugs.

Authors:  M A Spiteri; D G James
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

7.  Phenothiazines and eye complications.

Authors:  M Valentine; P Jardine
Journal:  Br Med J       Date:  1966-09-03

8.  Chlorpromazine melanosis.

Authors: 
Journal:  Br Med J       Date:  1967-09-09

9.  Eye and skin changes in psychiatric patients treated with chlorpromazine.

Authors:  M B Mathalone
Journal:  Br J Ophthalmol       Date:  1967-02       Impact factor: 4.638

10.  Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.

Authors:  S Lal; D Bloom; B Silver; B Desjardins; B Krishnan; J Thavundayil; T Thompson
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.